Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements

Journal of Lipid Research

Volumn 50, Issue 5, 2009, Pages 820-831

  Li, Hai ^a   Chen, Wei ^a   Zhou, Yue ^a   Abidi, Parveen ^a   Sharpe, Orr ^a   Robinson, William H ^a   Kraemer, Frederic B ^a   Liu, Jingwen ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

3 untranslated region; Berberine; Hypercholesterolemia; MRNA stability

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; KH TYPE SPLICING REGULATORY PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; REGULATOR PROTEIN; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BERBERINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; KHSRP PROTEIN, HUMAN; POLYPYRIMIDINE TRACT BINDING PROTEIN; PTBP1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA STABILITY; CELL LINE; GENETICS; METABOLISM; MOLECULAR GENETICS; REPORTER GENE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BERBERINE; CELL LINE; GENES, REPORTER; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RECEPTORS, LDL; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANS-ACTIVATORS;

EID: 67649729571     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800375-JLR200     Document Type: Article

References (44)

1. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of the membrane bound transcription factor. Cell. 89: 331-340.
2. Brown, M. S., and J. L. Goldstein. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA. 96: 11041-11048.
3. Seidah, N. G. 2003. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):liver regeneration and neuronal differentiation. Proc. Natl. Acad. Sci. USA. 100: 928-933.
4. Abifadel, M., M. Varret, J. P. Rabès, D. Allard, K. Ouguerram, M. Devillers, C. Cruaud, S. Benjannet, L. Wickham, D. Erlich, et al. 2003. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34: 154-156.
5. Maxwell, K. N., R. E. Soccio, E. M. Duncan, E. Sehayek, and J. L. Breslow. 2003. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J. Lipid Res. 44: 2109-2119.
6. Horton, J. D., N. A. Shah, J. A. Warrington, N. N. Anderson, S. W. Park, M. S. Brown, and J. L. Goldstein. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA. 100: 12027-12032.
7. Horton, J. D., J. C. Cohen, and H. H. Hobbs. 2007. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem. Sci. 32: 71-77.
8. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59: 423-450.
9. Yamamoto, T., C. G. Davis, M. S. Brown, W. J. Schneider, M. L. Casey, J. L. Goldstein, and D. W. Russell. 1984. The human LDL receptor: a cystein-rich protein with multiple Alu sequence in its mRNA. Cell. 39: 27-38.
10. Wilson, G. M., M. Z. Vasa, and R. G. Deeley. 1998. Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3' untranslated region. J. Lipid Res. 39: 1025-1032.
11. Zhang, T., V. Kruys, G. Huez, and C. Gueydan. 2002. AU-rich element-mediated translational control: complexity and multiple activity of trans-activating factors. Biochem. Soc. Trans. 30: 952-958.
12. Barreau, C., L. Paillard, and B. H. Osborne. 2005. Survey and summary: AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33: 7138-7150.
13. Gherzi, R., M. Trabucchi, M. Ponassi, T. Ruggiero, G. Corte, C. Moroni, C-Y. Chen, K. S. Khabar, J. S. Andersen, and P. Briata. 2006. The RNA-binding protein KSRP promotes decay of b-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol. 5: e5.
14. Ruggiero, T., M. Trabucchi, M. Ponassi, G. Corte, C. Y. Chen, L. al-Haj, K. S. Khabar, P. Briata, and R. Gherzi. 2007. Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling. BMC Mol. Biol. 8: 28.
15. Raineri, I., D. Wegmueller, B. Gross, U. Certa, and C. Moroni. 2004. Roles of AUF1 isoforms, HuR, and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res. 32: 1279-1288.
16. Pullmann, R., Jr., H. H. Kim, K. Abdelmohsen, A. Lal, J. L. Martindale, X. Yang, and M. Gorospe. 2007. Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol. Cell. Biol. 27: 6265-6278.
17. Liao, B., Y. Hu, and G. Brewer. 2007. Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation. Nat. Struct. Mol. Biol. 14: 511-518.
18. David, P. S., R. Tanveer, and J. D. Port. 2007. FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1. RNA. 13: 1453-1468.
19. Kong, W., J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, Y. Wang, Z. Wang, S. Si, H. Pan, et al. 2004. Berberine is a promising novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10: 1344-1352.
20. Abidi, P., Y. Zhou, J. D. Jiang, and J. Liu. 2005. ERK-dependent regulation of hepatic LDL receptor expression by herbal medicine berberine. Arterioscler. Thromb. Vasc. Biol. 25: 2170-2176.
21. Abidi, P., W. Chen, F. B. Kraemer, H. Li, and J. Liu. 2006. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple active components and new action mechanisms. J. Lipid Res. 47: 2134-2147.
22. Chen, W., S. Wang, Y. Ma, Y. Zhou, H. Liu, P. Strnad, F. B. Kraemer, R. M. Krauss, and J. Liu. 2008. Analysis of polymorphisms in 3′ untranslated region of LDL receptor gene and their effect on plasma cholesterol levels and drug response. Int. J. Mol. Med. 21: 345-353.
23. Lehmann, D. M., C. A. Galloway, M. P. Sowden, and H. C. Smith. 2006. Metabolic regulation of ApoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Nucleic Acids Res. 34: 3299-3308.
24. Kaufmann, I., G. Martin, A. Friedlein, H. Langen, and W. Keller. 2004. Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. EMBO J. 23: 616-626.
25. Hosoda, N., F. Lejeune, and L. E. Maquat. 2006. Evidence that poly (A) binding protein C1 binds nuclear pre-mRNA poly(A) tails. Mol. Cell. Biol. 26: 3085-3097.
26. Behm-Ansmant, I., D. Gatfield, J. Rehwinkel, V. Hilgers, and E. Izaurralde. 2007. A conversed role for cytoplasmic poly(A)-binding protein 1 (PABPC1) in nonsense-mediated mRNA decay. EMBO J. 26: 1591-1601.
27. Kajita, Y., J. Nakayama, M. Aizawa, and F. Ishikawa. 1995. The UUAG-specific RNA binding protein, heterogeneous nuclear ribonucleotprotein D0. J. Biol. Chem. 270: 22167-22175.
28. Kawamura, H., Y. Tomozoe, T. Akaqi, D. Kamei, M. Ochiai, and M. Yamada. 2002. Identification of the nucleocytoplasmic shuttling sequence of heterogeneous nuclear ribonucleoprotein D-like protein JKTBP and its interaction with mRNA. J. Biol. Chem. 277: 2732-2739.
29. Ostareck-Lederer, A., D. H. Ostareck, and M. W. Hentze. 1998. Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2. Trends Biochem. Sci. 23: 409-411.
30. Thiele, B. J., A. Doller, T. Kähne, R. Pregla, R. Hetzer, and V. Regitz-Zagrosek. 2004. RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis. Circ. Res. 95: 1058-1066.
31. Kaneko, S., O. Rozenblatt-Rosen, M. Meyerson, and J. L. Manley. 2007. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3′ processing and transcription termination. Genes Dev. 21: 1779-1789.
32. Bollig, F., R. Winzen, M. Gaestel, S. Kostka, K. Resch, and H. Holtmann. 2003. Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem. Biophys. Res. Commun. 301: 665-670.
33. Liu, J., R. Streiff, Y. L. Zhang, R. E. Vestal, M. J. Spence, and M. R. Briggs. 1997. Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M. J. Lipid Res. 38: 2035-2048.
34. Liu, J., T. E. Ahlborn, M. R. Briggs, and F. B. Kraemer. 2000. Identification of a novel sterol-independent regulatory element (SIRE) in the human LDL receptor promoter. J. Biol. Chem. 275: 5214-5221.
35. Paradis, C., P. Cloutier, L. Shkreta, J. Toutant, K. Klarskov, and B. Chabot. 2007. hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c. RNA. 13: 1-14.
36. Wilson, G. M., E. A. Roberts, and R. G. Deeley. 1997. Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. J. Lipid Res. 38: 437-446.
37. Nakahara, M., H. Fujii, P. R. Maloney, M. Shimizu, and R. Sato. 2002. Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA. J. Biol. Chem. 277: 37229-37234.
38. Sarkar, B., Q. Xi, C. He, and R. J. Schneider. 2003. Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell. Biol. 23: 6685-6693.
39. Wagner, B. J., C. T. DeMaria, Y. Sun, G. M. Wilson, and G. Brewer. 1998. Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics. 48: 195-202.
40. Lu, J. Y., N. Bergman, N. Sadri, and R. J. Schneider. 2007. Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay. RNA. 12: 883-893.
41. Laroia, G., R. Cuesta, G. Brewer, and R. J. Schneider. 1999. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science. 284: 499-502.
42. Wagner, E. J., and M. A. Garcia-Blanco. 2001. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21: 3281-3288.
43. Söderberg, M., F. Raffalli-Mathieu, and M. A. Lang. 2007. Regulation of the murine inducible nitric oxide synthase gene by dexamethasone involves a heterogenous nuclear ribonucleoprotein I (hnRNP I) dependent pathway. Mol. Immunol. 44: 3204-3210.
44. Liu, H., C. Fenollar-Ferrer, A. Cao, C. Anselmi, P. Carloni, and J. Liu. 2009. Molecular dissection of human oncostatin M-mediated signal transductions through site-directed mutagenesis. Int. J. Mol. Med. 23: 161-172.